| abstract |
The present invention relates to the use of polysiloxanes containing at least one quaternary ammonium group as formulation auxiliaries in formulations of pharmaceutically and veterinary active compounds, and to compositions comprising a) a pharmaceutically or veterinary active compound and b) a polysiloxane derivative containing at least one quaternary ammonium group per molecule, if appropriate, further auxiliaries and carriers. |